| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4176299 | Seminars in Pediatric Infectious Diseases | 2006 | 6 Pages |
Abstract
The impact of influenza in the very young appears to be comparable to that in the elderly. Influenza vaccine strategy is changing to reflect that impact. Currently, the broader recommendations include vaccination with trivalent inactivated influenza vaccines (TIVs) for children aged 6 to 59 months. This article reviews TIV safety, immunogenicity, and efficacy in children, current vaccine recommendations, and vaccine administration and dosage.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Peter F. Wright,